Clinical Study
Subclinical Cardiovascular System Changes in Obese Patients with Juvenile Idiopathic Arthritis
Table 1
Demographic and clinical characteristics of the juvenile idiopathic arthritis (JIA) patients and the control group.
| | | JIA patients | Control group |
| | Number of patients | | | | Age, years | 13.0 (11.0–15.0) | 13.4 (12.0–15.0) | | Gender | | | | Boys | 26 (45%) | 14 (39%) | | Girls | 32 (55%) | 22 (61%) | | Height, meter | 1.5 (1.4–1.7) | 1.6 (1.5–1.7) | | Body mass, kg | 49.0 (33–65) | 51.5 (43–58) | | Age at JIA diagnosis, years | 9.0 (4.5–12.0) | | | Duration of the disease, years | 4.0 (2.0–5.5) | | | Activity of the disease | | | | Clinically active | 30 (52%) | | | Clinically inactive | 28 (48%) | | | Type of the disease | | | | Oligoarticular | 28 (48%) | | | Polyarticular | 26 (45%) | | | Systemic | 4 (7%) | | | Current treatment | | | | Corticosteroids | 42 (72%) | | | Methotrexate | 28 (48%) | | | Biologic agents | 14 (24%) | | | DMARDs | 9 (15%) | |
|
|
Values are the median (interquartile range) or numbers (%).
|
